Innovative Dermatology Biofrontera specializes in dermatological drugs and medical cosmetics, offering unique products like Ameluz® for skin cancer treatment. This focus presents opportunities to collaborate with clinics and hospitals seeking advanced skin care solutions.

Regulatory Milestone As the first German pharmaceutical firm with centralized European and US approval for in-house developed drugs, Biofrontera demonstrates strong regulatory expertise, making it an attractive partner for distributors aiming to expand in these regions.

Growth & Expansion Having recently gone public to fund growth initiatives, Biofrontera is in a development phase, creating sales opportunities through increased marketing efforts and expanding distribution channels for its innovative dermatology products.

Market Presence With products marketed across the EU and US, and a growing emphasis on skin care for damaged skin, there is potential for partnerships with dermatology clinics, cosmetic retailers, and skin care professionals to broaden product adoption.

Technology & Data Utilizing modern web and analytics tools, Biofrontera aims to enhance customer engagement and market reach. This creates opportunities for sales teams to leverage digital channels for targeted marketing and form strategic alliances with digital health platforms.